Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29030172
Abstract: Ovarian cancer (OC) is the leading cause of death among women with gynecologic malignancy. Breast Cancer Susceptibility Gene 1 (BRCA 1) and Breast Cancer Susceptibility Gene 2 (BRCA 2) germline mutations confer an estimated 20… read more here.
Keywords: risk reducing; gynecologic malignancy; reducing options; risk ... See more keywords